<?xml version='1.0' encoding='UTF-8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">3010297</PMID>
<DateCreated>
<Year>1986</Year>
<Month>06</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>1986</Year>
<Month>06</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-8424</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>83</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1986</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
<ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
</Journal>
<ArticleTitle>Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency.</ArticleTitle>
<Pagination>
<MedlinePgn>3402-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We have developed a recombinant DNA shuttle vector that permits the molecular analysis of mutations induced in human cells by chemical or physical mutagens. The vector is able to replicate as a plasmid in Escherichia coli and in Epstein-Barr virus (EBV)-transformed human lymphoblastoid cell lines and contains the herpes simplex virus type 1 thymidine kinase gene (HSV tk) as the target for mutagenesis studies. After introduction of the vector into an EBV-transformed lymphoblastoid cell line (LCL-721) by electroporation, approximately equal to 2% of the transfected cells expressed the vector-encoded gene for hygromycin resistance. Plasmid DNA isolated from cells immediately after selection for hygromycin resistance (10 population doublings posttransfection) contained mutations in the HSV tk gene at a frequency of 6 X 10(-5). Treatment of plasmid-bearing LCL-721 cells with N-ethyl-N-nitrosourea resulted in a dose-dependent increase of up to 15-fold in the frequency of mutations in the HSV tk gene. The dose-response for the induction of mutations in the plasmid-encoded gene closely paralleled that for the induction of mutations in the cellular gene for hypoxanthine (guanine) phosphoribosyltransferase.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Drinkwater</LastName>
<ForeName>N R</ForeName>
<Initials>NR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Klinedinst</LastName>
<ForeName>D K</ForeName>
<Initials>DK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>CA 07175</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA 09135</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA 37166</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
<NlmUniqueID>7505876</NlmUniqueID>
<ISSNLinking>0027-8424</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 2.4.2.8</RegistryNumber>
<NameOfSubstance UI="D007041">Hypoxanthine Phosphoribosyltransferase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.21</RegistryNumber>
<NameOfSubstance UI="D013937">Thymidine Kinase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>P8M1T4190R</RegistryNumber>
<NameOfSubstance UI="D005038">Ethylnitrosourea</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1974 Mar;71(3):631-3</RefSource>
<PMID Version="1">4362625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1985 Aug;5(8):1822-32</RefSource>
<PMID Version="1">3018528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mutat Res. 1978 Apr;50(1):137-44</RefSource>
<PMID Version="1">347279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Chem Biol Interact. 1979 Jul;26(2):197-205</RefSource>
<PMID Version="1">378447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1980 Jul;77(7):4251-5</RefSource>
<PMID Version="1">6933474</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1981 Oct;40(1):11-9</RefSource>
<PMID Version="1">6270367</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gene. 1981 Dec;16(1-3):287-95</RefSource>
<PMID Version="1">6282696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mutat Res. 1982 Dec;106(2):277-89</RefSource>
<PMID Version="1">7155168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1983 May;80(10):3010-4</RefSource>
<PMID Version="1">6304690</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1983 May;80(10):3015-9</RefSource>
<PMID Version="1">6574469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 1983 Jun 5;166(4):557-80</RefSource>
<PMID Version="1">6345791</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mutat Res. 1984 Jan;125(1):95-104</RefSource>
<PMID Version="1">6361545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1984 Mar;4(3):435-41</RefSource>
<PMID Version="1">6325877</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1984 Jun;81(12):3806-10</RefSource>
<PMID Version="1">6328526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1984 Oct;4(10):1951-60</RefSource>
<PMID Version="1">6095032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1984 Nov;4(11):2266-72</RefSource>
<PMID Version="1">6096690</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>EMBO J. 1984 Dec 20;3(13):3117-21</RefSource>
<PMID Version="1">6098464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1984 Dec;4(12):2929-31</RefSource>
<PMID Version="1">6098829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1985 Feb;5(2):410-3</RefSource>
<PMID Version="1">2983194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1985 Dec;82(24):8606-10</RefSource>
<PMID Version="1">3001711</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Cell Biol. 1985 Sep;5(9):2265-71</RefSource>
<PMID Version="1">3869955</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 1975 Nov 5;98(3):503-17</RefSource>
<PMID Version="1">1195397</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005038">Ethylnitrosourea</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D005822">Genetic Vectors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004854">Herpesvirus 4, Human</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007041">Hypoxanthine Phosphoribosyltransferase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008214">Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009152">Mutagenicity Tests</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000592">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009154">Mutation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013937">Thymidine Kinase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014162">Transfection</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC323522</OtherID>
</MedlineCitation>
